EMMA MOORE: Open Payments
NPI 1861123440 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 41 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $571 · 2025 $926
Food & beverage: $926
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $196 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $128 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $99 |
| Exact Sciences Corporation | 3 | $68 |
| Lilly USA, LLC | 3 | $68 |
| Eisai Inc. | 2 | $58 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| TOLMAR, INC. | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
Products named: XIFAXAN, Kerendia, Wegovy, Cologuard Collection Kit, MOUNJARO, Leqembi, TRELEGY ELLIPTA, REXULTI.
Industry payments across TX — which companies pay providers there.
